Navigation Links
Beckman Coulter Announces First in Series of Flow Cytometry Product Introductions for 2009
Date:3/12/2009

Gallios(TM) Flow Cytometry System Offers New Standard of Performance for Researchers

ORANGE COUNTY, Calif., March 12 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, and manufacturer of products that simplify and automate complex biomedical testing, announced today that it has launched the Gallios Flow Cytometer, the first of several instrument, software and reagent introductions in the year for both clinical and research applications in flow cytometry.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

The new Gallios Flow Cytometer, targeted to the research market, delivers analytical excellence combined with high speed data collection. Features - including advanced optics, patented electronics design, and novel software tools - improve lab workflow and quality control, delivering increased sensitivity and resolution in less time and at higher speeds. Researchers can readily see small and subtle changes in cell populations, and the system accelerates data generation.

"Every aspect of the Gallios design increases application performance. When combined with our broad and high quality reagent portfolio, we provide a new and powerful solution for cellular analysis, increasing productivity and improving the reliability and reproducibility of results," said Cynthia Collins, group vice president of Cellular Analysis at Beckman Coulter.

The analyzer's efficient, compact design allows laboratories to maximize valuable space. The system comes in three scaleable configurations that allow for future addition of more lasers and fluorescence detectors as the need for complex multi-color flow cytometry expands.

Collins added, "We are adding a number of exciting products to our flow cytometry portfolio this year. They are a testament to our commitment to enhancing the efficiency of flow cytometry laboratories around the globe."

About Beckman Coulter

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits and operating-type lease payments, represents approximately 78 percent of the company's 2008 annual revenue of $3.1 billion. For more information, visit www.beckmancoulter.com.

    Contacts:  Mary Luthy, Beckman Coulter   Cynthia Skoglund, Beckman Coulter
               Corporate Communications      Investor Relations
               (714) 773-7964                (714) 773-7620


'/>"/>
SOURCE Beckman Coulter, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Beckman Coulter to Present at Upcoming Healthcare Conferences
2. Beckman Coulter Announces Third Quarter 2008 Results
3. Beckman Coulter to Present at the Morgan Stanley Global Healthcare Unplugged Conference
4. Beckman Coulter Announces First Quarter 2008 Earnings to be Released on Wednesday, April 30, 2008, Before Market Opens
5. Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10.8% and 9.2%, Respectively; 2007 Earnings Per Share Beat Outlook
6. Beckman Coulter to Present at the 2007 RBC Capital Markets Healthcare Conference
7. Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako
8. Beckman Coulter to Present at the Credit Suisse Global Healthcare Conference
9. Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
10. Beckman Coulter Announces Licensing Option Agreements for Cancer Genes with Johns Hopkins University
11. Meditor Pharmaceuticals (North American) Ltd. announces the closing of a merger agreement with American Medical Technologies, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: ... and sells medical devices and wearable sleep respiratory products ... cooperation agreement with Hongyuan Supply Chain Management Co., Ltd. ... 20, 2016, to develop Dehaier,s new Internet medical technology ... will leverage Hongyuan Supply Chain,s sales platform to reach ...
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
Breaking Medicine Technology: